Buy or sell Human Longevity stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Human Longevity Stock

Genomics and cell therapy

Founded

2013

Notable Investors

Illumina

Headquarters

San Diego CA, US

Total Funding

$300M

About Human Longevity Stock

Human Longevity, Inc. (HLI) is the genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived. HLI combines the largest database of genomic and phenotypic data with machine learning to drive discoveries and revolutionize the practice of medicine. HLI’s business areas include the HLI Health Nucleus, a genomic powered clinical research center which uses whole genome sequence analysis, advanced clinical imaging and innovative machine learning, along with curated personal health information, to deliver the most complete picture of individual health; HLIQ™ Whole Genome and HLIQ Oncology.

Investors

Funding History

March 2014$80.0M
April 2016$220M

Management

Co-Founder & CEO

J. Venter

Co-Founder & Vice Chairman

Robert Hariri

Chief Information Officer

Yaron Turpaz

Medical Director

Brad Perkins

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Human Longevity or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 70K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo